Scott D. Grimes - 03 Aug 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Issuer symbol
CDLX
Transactions as of
03 Aug 2021
Net transactions value
-$352,892
Form type
4
Filing time
04 Aug 2021, 17:02:27 UTC
Previous filing
03 Aug 2021
Next filing
19 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Sale $61,121 -527 -0.22% $115.98* 237,147 03 Aug 2021 Direct F1, F2
transaction CDLX Common Stock Sale $157,146 -1,346 -0.57% $116.75* 235,801 03 Aug 2021 Direct F1, F3
transaction CDLX Common Stock Sale $47,222 -401 -0.17% $117.76* 235,400 03 Aug 2021 Direct F1, F4
transaction CDLX Common Stock Sale $38,755 -326 -0.14% $118.88* 235,074 03 Aug 2021 Direct F1, F5
transaction CDLX Common Stock Sale $48,648 -400 -0.17% $121.62* 234,674 03 Aug 2021 Direct F1, F6
holding CDLX Common Stock 71,112 03 Aug 2021 See Footnote F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $115.29 to $116.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6) to this Form 4.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $116.29 to $117.23, inclusive.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $117.35 to $118.19, inclusive.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $118.49 to $119.27, inclusive.
F6 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $121.50 to $121.74, inclusive.
F7 The reportable securities are held by the 2013 Scott Grimes GRAT UAD.